How big is Organon’s biosimilar push for Sun Pharma?
Summary
The Organon acquisition positions Sun Pharma in the global biosimilars market amid efforts to monetize biologics patent expiries.
Description
The Organon acquisition positions Sun Pharma in the global biosimilars market amid efforts to monetize biologics patent expiries.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source